XML 52 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2021

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth reconciliations of the numerators and denominators used to compute basic and diluted earnings per Class A ordinary share for the year ended December 31, 2021 (in thousands, except per share amounts).

									Year Ended December 31, 2021
Numerator
Consolidated net income									$	1,241,201
Less: Net income attributable to Continuing Investors Partnerships									297,321
Less: Net income attributable to Legacy Investors Partnerships and RPSFT									324,152
Net income attributable to Royalty Pharma plc - basic and diluted									$	619,728
Denominator
Weighted average Class A ordinary shares outstanding - basic									414,794
Add: Dilutive effect of unvested RSUs									8
Weighted average Class A ordinary shares outstanding - diluted									414,802
Earnings per Class A ordinary share - basic									$	1.49
Earnings per Class A ordinary share - diluted									$	1.49

The following table sets forth reconciliations of the numerators and denominators used to compute basic and diluted earnings per Class A ordinary share for the year ended December 31, 2020 (in thousands, except per share amounts).

						Year Ended December 31, 2020
Numerator
Consolidated net income						$	1,701,954
Less: Net income attributable to Continuing Investors Partnerships prior to the IPO (1)						479,842
Less: Net income attributable to Continuing Investors Partnerships subsequent to the IPO						316,993
Less: Net income attributable to Legacy Investors Partnerships and RPSFT						409,921
Net income attributable to Royalty Pharma plc - basic and diluted						$	495,198
Denominator
Weighted average Class A ordinary shares outstanding - basic						375,444
Add: Dilutive effect of unvested RSUs						11
Weighted average Class A ordinary shares outstanding - diluted						375,455
Earnings per Class A ordinary share - basic						$	1.32
Earnings per Class A ordinary share - diluted						$	1.32

(1)     Reflected as Net income attributable to controlling interest on the consolidated statements of operations

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration